CAS 138514-32-6
:5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methylester, (6R,7R)-
Description:
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, with the CAS number 138514-32-6, is a complex chemical compound characterized by its bicyclic structure, which includes both sulfur and nitrogen atoms. This compound features a carboxylic acid functional group, contributing to its acidity and potential reactivity. The presence of thiazole rings indicates that it may exhibit biological activity, as thiazoles are often found in pharmaceuticals. The compound also contains a methoxyimino group, which can enhance its stability and influence its interaction with biological targets. Additionally, the ester functionality suggests that it may undergo hydrolysis, leading to the release of the corresponding acid. The stereochemistry indicated by the (6R,7R) configuration implies specific spatial arrangements of atoms, which can significantly affect the compound's biological activity and pharmacokinetics. Overall, this compound's unique structural features and functional groups suggest potential applications in medicinal chemistry, particularly in the development of antimicrobial agents or other therapeutic compounds.
Formula:C25H28N6O7S3
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
Me 1207E
CAS:Me 1207E is a potent protein kinase inhibitor that has shown promising results in the treatment of various types of cancer. This analog of a Chinese medicinal compound has been found to induce apoptosis and inhibit cell replication in human cancer cells. Me 1207E has also been shown to be effective as an anticancer agent in animal models, with significant tumor growth inhibition observed in mice. This inhibitor can be detected in urine after administration, making it a convenient option for monitoring therapeutic levels. With its potent activity against cancer cells and promising preclinical data, Me 1207E represents a promising avenue for the development of novel cancer therapies.Formula:C25H28N6O7S3Purity:Min. 95%Molecular weight:620.7 g/mol


